Human Genome Epidemiology Literature Finder
Rare Diseases
Records 1 - 30 (of 489 Records) |
Query Trace: Chronic Lymphocytic Leukemia[original query] |
---|
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia. Leukemia 2023 9 . Ludovic Jondreville, Lea Dehgane, Cecile Doualle, Luce Smagghe, Beatrice Grange, Frederic Davi, Leticia K Lerner, Delphine Garnier, Clotilde Bravetti, Olivier Tournilhac, Damien Roos-Weil, Marouane Boubaya, Elise Chapiro, Santos A Susin, Florence Nguyen-Kh |
Genetic Predictors of Ibrutinib-Related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Issam S Hamadeh, Jai N Patel, Ryan Jacobs, Hang Zeng, Jiaxian He, Bei Hu, Tamara Kay Moyo, Amy Soni, Steven Park, Ed Copelan, Belinda Avalos, Alicia Hamilton, Nury Steuerwald, Nilanjan Gho |
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL. HemaSphere 2023 9 7 (10): e951. Paul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, Wouter Doff, Julie M N Dubois, Melissa Rijken, Jorn L J C Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten J Gussinklo, Peter J M Valk, Laura M Faber, Peter E Westerweel, Arnon P Kater, Mark-David Levin, Anton W Langer |
Copy Number Variations and Gene Mutations Identified by Multiplex Ligation-Dependent Probe Amplification in Romanian Chronic Lymphocytic Leukemia Patients. Journal of personalized medicine 2023 8 13 (8): . Beata Balla, Florin Tripon, Marcela Candea, Claudia Banes |
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study. Frontiers in medicine 2023 8 10 1231003. Andrea Michelerio, Carlo Tomasini, Giacomo Fiandrino, Mara De Amici, Marzia Varettoni, Irene Defrancesco, Chiara Cavalloni, Valeria Brazzelli, Federica Derlino, Marco Paulli, Luca Arcaini, Camilla Vassal |
Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. Blood 2023 7 . P Martijn Kolijn, Florentin Späth, Mouhamad Khouja, Paul J Hengeveld, Lina Van Der Straten, Nikos Darzentas, Magnus Hultdin, James McKay, Christiane Pott, Roel C H Vermeulen, Anton W Langer |
Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population. Gene 2023 7 883 147673. Menna Al-Adl, Afaf El-Said, Ahmed El-Sebaie, Sherif Refaat, Magdy M Youss |
A CAPTIVATEing Analysis for Higher-Risk CLL. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF2. Kerry A Roge |
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF9. John N Allan, Ian W Flinn, Tanya Siddiqi, Paolo Ghia, Constantine S Tam, Thomas J Kipps, Paul M Barr, Anna Elinder Camburn, Alessandra Tedeschi, Xavier C Badoux, Ryan Jacobs, Bryone J Kuss, Livio Trentin, Cathy Zhou, Anita Szoke, Christopher Abbazio, William G Wier |
Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study. Asian Pacific journal of cancer prevention : APJCP 2023 6 24 (6): 1971-1977. Selim Sayin, Emrah Kiliacslan, Murat Yildirim, Hacer Berna Afacan Ozturk, Esra Safak Yilmaz, Murat Albayrak, M Kursat Kaptan, Meltem Ay |
B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 . Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno, Susan M O'Brien, Daniel Jones, Leo W K Cheung, Elizabeth Chong, Kevin Kwei, James P Dean, Danelle F James, Adrian Wiestn |
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets. Neurology(R) neuroimmunology & neuroinflammation 2023 5 10 (4): . Francesca Castellani, Andrea Visentin, Erika Schirinzi, Alessandro Salvalaggio, Mario Cacciavillani, Cinzia Candiotto, Claudia Baratè, Alessandro Cellini, Roberta Bertorelle, Gabriele Siciliano, Livio Trentin, Chiara Bria |
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 OF1-OF10. Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Xin Tian, Lita A Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestn |
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? International journal of molecular sciences 2023 5 24 (9): . Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Rob Ter Horst, Angelica Macauda, Paloma García-Martín, Yolanda Benavente, Stefano Landi, Alyssa Clay-Gilmour, Yasmeen Niazi, Blanca Espinet, Juan José Rodríguez-Sevilla, Eva María Pérez, Rossana Maffei, Gonzalo Blanco, Matteo Giaccherini, James R Cerhan, Roberto Marasca, Miguel Ángel López-Nevot, Tzu Chen-Liang, Hauke Thomsen, Irene Gámez, Daniele Campa, Víctor Moreno, Silvia de Sanjosé, Rafael Marcos-Gragera, María García-Álvarez, Trinidad Dierssen-Sotos, Andrés Jerez, Aleksandra Butrym, Aaron D Norman, Mario Luppi, Susan L Slager, Kari Hemminki, Yang Li, Sonja I Berndt, Delphine Casabonne, Miguel Alcoceba, Anna Puiggros, Mihai G Netea, Asta Försti, Federico Canzian, Juan Sai |
Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles. Frontiers in oncology 2023 3 13 1120867. Deng Xinyue, Zhang Meilan, Wang Jiachen, Zhou Xiaoxi, Xiao M |
Low plateletcrit is associated with reduced progression: Free and overall survival in chronic lymphocytic leukemia. Journal of medical biochemistry 2023 3 42 (2): 274-281. Ozbalci Demircan, Alanoglu Emine Guchan, Findos Eda, Eroglu Hande N |
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax. International journal of molecular sciences 2023 3 24 (6): . Kotmayer Lili, László Tamás, Mikala Gábor, Kiss Richárd, Lévay Luca, Hegyi Lajos László, Gróf Stefánia, Nagy Tibor, Barna Gábor, Farkas Péter, Weisinger Júlia, Nagy Zsolt, Balogh Alexandra, Masszi Tamás, Demeter Judit, Sulák Adrienn, Kohl Zoltán, Alizadeh Hussain, Egyed Miklós, Pettendi Piroska, Gergely Lajos, Plander Márk, Pauker Zsolt, Masszi András, Matolcsy András, Szász Róbert, Bödör Csaba, Alpár Don |
Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of MYD88 Mutations. International journal of molecular sciences 2023 2 24 (4): . Ahn Ari, Kim Hoon Seok, Kim Tong-Yoon, Lee Jong-Mi, Kang Dain, Yu Haein, Lee Chae Yeon, Kim Yonggoo, Eom Ki-Seong, Kim Myungsh |
Sequence variation of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene in chronic lymphocytic leukemia and healthy volunteer subjects. Archives of virology 2023 12 169 (1): 1. Zahra Vafapour, Fatemeh Hosseini Tabatabaie, Seyed Younes Hosseini, Shirin Haghighat, Seyed Mohammad Ali Hashemi, Afagh Moattari, Jamal Sarva |
Evaluation the -174G>C Genetic Polymorphism of Interleukin-6 in Iranian Patients with Chronic Lymphocytic Leukemia. Iranian journal of pathology 2023 11 18 (4): 392-397. Zakieh Rostamzadeh Khameneh, Mahshid Mohammadian, Ali Eishi Oskuie, Rahim Asghari, Mohadeseh Nema |
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia. Annals of hematology 2023 11 . Chun-Yu Shang, Li-Ye Bei, Jia-Zhu Wu, Hao-Rui Sheng, Hua Yin, Jin-Hua Liang, Li Wang, Jian-Yong Li, Yue Li, Wei |
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
TP53 Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia. Frontiers in oncology 2023 11 13 1272876. Asma Ounalli, Imen Moumni, Amal Mechaal, Aya Chakroun, Mbarka Barmat, Rim El Elj Rhim, Samia Menif, Ines Saf |
BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib. Blood advances 2023 1 . Bonfiglio Silvia, Sutton Lesley-Ann, Ljungström Viktor, Capasso Antonella, Pandzic Tatjana, Weström Simone, Foroughi-Asl Hassan, Skaftason Aron, Gellerbring Anna, Lyander Anna, Gandini Francesca, Gaidano Gianluca, Trentin Livio, Bonello Lisa, Reda Gianluigi, Bödör Csaba, Stavroyianni Niki, Tam Constantine S, Marasca Roberto, Forconi Francesco, Panayiotidis Panayiotis, Ringshausen Ingo, Jaksic Ozren, Frustaci Anna Maria, Iyengar Sunil, Coscia Marta, Mulligan Stephen P, Ysebaert Loïc, Strugov Vladimir, Pavlovsky Carolina, Walewska Renata, Österborg Anders, Cortese Diego, Ranghetti Pamela, Baliakas Panagiotis, Stamatopoulos Kostas, Scarfò Lydia, Rosenquist Richard, Ghia Pao |
Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity. Frontiers in oncology 2023 1 12 1079772. Sofou Electra, Zaragoza-Infante Laura, Pechlivanis Nikolaos, Karakatsoulis Georgios, Notopoulou Sofia, Stavroyianni Niki, Psomopoulos Fotis, Georgiou Elisavet, de Septenville Anne Langlois, Davi Frederic, Agathangelidis Andreas, Chatzidimitriou Anastasia, Stamatopoulos Kost |
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 2023 1 37 (2): 504. Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richa |
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: Pooled analysis of 5 clinical trials. Blood advances 2024 4 . Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby A Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Maria Butturini, Ugochinyere Emeribe, John C By |
[Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2024 4 45 (2): 197-202. T L Qiu, J Y Li, Y X |
IMMUNOPHENOTYPE OF LEUKEMIC CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH NOTCH1 AND SF3B1 GENE MUTATIONS. Experimental oncology 2024 1 45 (3): 322-327. N Golyarnik, ? ?????????, G Movchan, Z Martina, I Dyagil, A Chumak, D Bazy |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 20, 2024
- Content source: